王建平,李晶,邓珊珊,孙蓉,呙劲松,郑薇,董晨珊,黄干,周智广.衡阳地区初诊2型糖尿病患者谷氨酸脱羧酶抗体筛查.[J].中南医学科学杂志.,2011,39(2):170-172.
衡阳地区初诊2型糖尿病患者谷氨酸脱羧酶抗体筛查
Screening of GADA in Newly Diagnosed Type 2 Diabetic Patients in Hengyang Area
投稿时间:2010-10-15  
DOI:
中文关键词:  2型糖尿病  成人隐匿性自身免疫性糖尿病  谷氨酸脱羧酶抗体
英文关键词:T2DM  LADA  GADA
基金项目:湖南省教育厅资助(09C844).
作者单位
王建平1,李晶1,邓珊珊1,孙蓉1,呙劲松1,郑薇1,董晨珊1,黄干2,周智广2 1.南华大学第二附属医院 内分泌科湖南 衡阳 4210012.中南大学湘雅二医院 代谢内分泌研究所 
摘要点击次数: 1017
全文下载次数: 928
中文摘要:
      目的探讨衡阳地区初诊2型糖尿病(T2DM)患者中成人隐匿性自身免疫性糖尿病(LADA)的患病率及其临床特征。方法对102例病程1年以内非酮症起病的初诊T2DM患者采用放射配体法检测谷氨酸脱羧酶抗体(GADA),同时测量身高、体重、体质指数(BMI)、血压,检测空腹血糖、空腹C肽(FCP)、糖化血红蛋白(HbA1c)、血脂、超敏促甲状腺激素(uTSH)、甲状腺球蛋白抗体(TG-Ab)与甲状腺过氧化物酶抗体(TPOAb),比较GADA阳性患者与GADA阴性患者之间的临床特征与生化特征差异。结果初诊T2DM患者GADA阳性率即LADA患病率为9.8%(10/102);与GADA阴性患者比较,GADA阳性LADA患者BMI较小,空腹C肽水平较低,uTSH异常检出率与TPOAb阳性率增高(均P<0.05)。结论衡阳地区初诊2型糖尿病患者中存在一定比例的LADA患者;对于BMI较小、胰岛功能较差的初发T2DM患者应及早检测GADA。
英文摘要:
      ObjectiveTo investigate prevalence and clinical feature in newly diagnosed type 2 diabetic(T2DM) patients in Hengyang area.Methods102 newly diagnosed type 2 diabetic patients whose course of disease within one year and without ketosis were measured glutaminic acid decarboxylase antibodies(GADA)by radioligand binding assay.At the same time,Ht,Wt,BMI,BP,FBG,FCP,HbA1c,TG,TC,HDLC,LDLC,uTSH,TG-Ab and TPO-Ab were measured,and the clinical and biochemistry difference between the GADA positive patients and GADA negative ones were compared.ResultsThe positive rate of GADA in patients with T2DM was 9.8%;Compared with GADA negative patients,BMI and FCP level was lower in patients of LADA with GADA positive,but the uTSH abnormal rate and the positive rate of TPO-Ab were higher(P<0.05).ConclusionsThere is certain proportion LADA patients in newly diagnosed type 2 diabetic patients in Hengyang area.The patient who possess a lower BMI,faintish function of pancreatic islet and suffering T2DM for first time should exam the GADA as soon as possible.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=2FA0F68BFBCCF32C5BED50A6486A8C5E7A31CFB17280A41141C482A28CB1F17B5BAF331377F2506EC0912267143E04E6CFF2D1D373BF69687EEE5232A2220C5896E3F6598B5EC0365A94F28BC7150CF8&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=9377ED8094509821&aid=DD26710B4E10EE67E55CE0F5FBAADE46&vid=&iid=0B39A22176CE99FB&sid=C5F8B8CB20F1B3D8&eid=9D453329DCCABB94&fileno=20110214&flag=1&is_more=0">